The Motley FoolWed, 20 May 2026 23:01:49 GMTWhy Relay Therapeutics Stock Popped on WednesdayRLAY+4.92%
Seeking AlphaWed, 20 May 2026 08:50:17 GMTRelay Therapeutics: Zovegalisib Is Becoming A Platform In DisguiseRLAY+4.92%
Seeking AlphaWed, 20 May 2026 03:10:53 GMTRelay Therapeutics, Inc. (RLAY) Discusses Initial Clinical Data for Zovegalisib in Vascular Anomalies TranscriptRLAY+4.92%
Investors Business DailyTue, 19 May 2026 10:00:31 GMTThis Biotech's Drug Just Wiped The Floor With ForecastsRLAY+4.92%
Zacks Investment ResearchTue, 05 May 2026 23:10:39 GMTRelay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Lags Revenue EstimatesRLAY+4.92%
Seeking AlphaMon, 27 Apr 2026 20:21:31 GMTRelay Therapeutics, Inc. (RLAY) Discusses Zovegalisib Triplet Data and First-Line Breast Cancer Strategy TranscriptRLAY+4.92%
Zacks Investment ResearchMon, 06 Apr 2026 14:15:29 GMTRelay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains?RLAY+4.92%
The Motley FoolThu, 19 Mar 2026 19:03:04 GMTIs Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet.RLAY+4.92%
Seeking AlphaWed, 11 Mar 2026 16:42:22 GMTRelay Therapeutics, Inc. (RLAY) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptRLAY+4.92%
Zacks Investment ResearchWed, 11 Mar 2026 14:06:09 GMTRelay Therapeutics (RLAY) Soars 5.4%: Is Further Upside Left in the Stock?RLAY+4.92%
Seeking AlphaFri, 06 Mar 2026 20:45:57 GMTRelay Therapeutics, Inc. (RLAY) Presents at TD Cowen 46th Annual Health Care Conference TranscriptRLAY+4.92%
Seeking AlphaThu, 05 Mar 2026 10:42:11 GMTRelay Therapeutics: Breakthrough Designation Sets The Stage For A Key Zovegalisib Data CatalystRLAY+4.92%
The Motley FoolFri, 27 Feb 2026 15:58:28 GMTRelay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 MillionRLAY+4.92%
Zacks Investment ResearchFri, 27 Feb 2026 00:01:14 GMTRelay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue EstimatesRLAY+4.92%
